Sunday, October 25, 2026

AI Funding & Investment

3 articles

OpenAI Raises $110 Billion as Tech Sector Faces Sharp Selloff

OpenAI Raises $110 Billion as Tech Sector Faces Sharp Selloff

OpenAI secured $110 billion in funding during late February 2026 market turbulence that saw the Dow drop over 500 points. The fundraise stands as the largest AI investment round ever, closing amid geopolitical tensions that drove oil prices higher and Bitcoin toward $66,000.

ViaNews Editorial Team (AI department)•
Traditional VCs Reclaim 95% of AI Mega-Rounds as Tiger Global, SoftBank Retreat

Traditional VCs Reclaim 95% of AI Mega-Rounds as Tiger Global, SoftBank Retreat

Venture capital firms now lead large AI financing rounds after Tiger Global and SoftBank Vision Fund cut their deal count by over 95% since 2021. The 2025 cohort includes just 1,440 companies raising $50M+—half the previous cycle—as traditional VCs dominate the AI wave with higher valuations and extended exit timelines.

ViaNews Editorial Team (AI department)•
What we know · the intelligence behind this page
Live from the substrate
What we're seeing
Enterprise Software Races to Govern and Consolidate Around Agentic AI
Enterprise software vendors are repositioning around autonomous AI agents. Salesforce is acquiring Braze, ServiceNow is launching agent governance tools (AI Passport, Super Intelligence Control Tower), SAP is pushing its 'Autonomous Enterprise', and Zeta is launching AthenaOS and its own inference model. Palantir is embedding itself in banking, aviation and sovereign AI infrastructure through partnerships with Customers Bank, Surf Air, Ondas and Armada. Governance, data sovereignty and enforced policy are emerging as preconditions for regulated sectors like finance. Investors such as Norwest see room to disrupt ERP and finance software, and they caution that AI should not be trusted with financial calculations. Consolidation and shareholder disputes (Salesforce/Braze, Tiny/Oso Cloud, ZenaTech/Boardwalktech) show the market reshaping.
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
Ford Motor Company
Both facts give cash for Ford Motor Company at the same point in time (2025-12-31; FY 2025 year-end and Q4 2025 year-end are the same date). Both are labelled USD, but the values are 23,356,000,000 and 23.356, which cannot both be true in USD. The two numbers agree once the second is read as billions (23.356 bn = 23,356,000,000), so the economic content is consistent and the conflict is a unit/scale error in the Q4 2025 record. The period is not the reason for the conflict: a Q4 and an FY figure at the same year-end date should match.
We flag conflicts openly ›
Recently verified
✓ Checked against the original source
4,994
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,994 facts checked against source5,500 source documents archived
Query this data → isubstrate.com